Novadip Biosciences
Accelerated Healing | Novadip | Tissue Regenerative Medicine
- Website
- novadip.com
- Last Round
- Extension RoundNov 2022
- Rounds
- 2
About
UCLouvain-derived regenerative medicine company developing NVD003 for congenital pseudarthrosis
Summary
Novadip Biosciences is a Biotech company. Its most recent funding was an Extension Round round in Nov 2022. Investors include European Investment Bank and CR-CP Life Science Fund.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2023
Sign up to see all 3 rounds
Series B through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/novadip-biosciences"><img src="https://indexed.vc/api/badge/company/novadip-biosciences" alt="Novadip Biosciences on Indexed.vc" width="260" height="76" /></a>